Menopause : the journal of the North American Menopause Society
-
The objectives of this study were to clarify changes in antimüllerian hormone (AMH) concentrations during the menopausal transition and to determine whether AMH may serve as a marker to predict the onset of menopause. ⋯ When AMH levels fall below detectable levels, women at the menopausal transition will progress to menopause within 3 years.
-
The goal of this study was to investigate sexual function in postmenopausal breast cancer patients treated with aromatase inhibitors. ⋯ Our findings suggest that sexual dysfunction in aromatase inhibitor-treated women is a greatly underestimated problem.
-
Randomized Controlled Trial Multicenter Study
Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
The aim of this study was to evaluate the effect of low-dose alendronate (ALN) treatment on bone mineral density (BMD) and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. ⋯ Treatment with low-dose ALN (70 mg every two weeks) in women with postmenopausal osteopenia or osteoporosis effectively increases lumbar spine and hip BMD, similar to treatment with standard-dose ALN. Low-dose ALN may be a cost-effective and safe protocol for treating osteopenia or osteoporosis in Chinese women.
-
Randomized Controlled Trial
Effect of aromatherapy massage on menopausal symptoms: a randomized placebo-controlled clinical trial.
Menopause is a significant event in most women's lives because it marks the end of a woman's natural reproductive life. The purpose of this study was to determine the effect of aromatherapy massage on menopausal symptoms. ⋯ The results of the study demonstrate that both massage and aromatherapy massage were effective in reducing menopausal symptoms. However, aromatherapy massage was more effective than only massage.